JM 82 articles written Jimmy McDermott Latest Articles Type 1 & Type 2 One Drop Blood Glucose Meter Now Sends Data Directly to Apple Watch new now next Read more One Drop Blood Glucose Meter Now Sends Data Directly to Apple Watch Type 1 & Type 2 Xeris Submits Glucagon Rescue Pen to FDA: A Dramatically Easier and Faster Treatment for Severe Hypoglycemia new now next Read more Xeris Submits Glucagon Rescue Pen to FDA: A Dramatically Easier and Faster Treatment for Severe Hypoglycemia Type 1 & Type 2 Top 10 New Product Highlights in the AADE 2018 Exhibit Hall conference pearls Read more Top 10 New Product Highlights in the AADE 2018 Exhibit Hall Type 1 & Type 2 Lilly Works to Get Nasal Glucagon Approved in US, Europe: A Dramatically More Convenient Treatment for Severe Hypoglycemia new now next Read more Lilly Works to Get Nasal Glucagon Approved in US, Europe: A Dramatically More Convenient Treatment for Severe Hypoglycemia Type 1 & Type 2 Experts Focus on Drug Safety, Continuous Glucose Monitoring, and Access at 2018 ADA Forum quotable quotes Read more Experts Focus on Drug Safety, Continuous Glucose Monitoring, and Access at 2018 ADA Forum Type 1 & Type 2 Companion Medical InPen Cleared for Use on Android & In Europe new now next Read more Companion Medical InPen Cleared for Use on Android & In Europe Type 1 Tandem’s Hybrid Closed Loop Pivotal Study: Control-IQ and Dexcom G6 trial watch Read more Tandem’s Hybrid Closed Loop Pivotal Study: Control-IQ and Dexcom G6 Type 1 FDA Approves Medtronic MiniMed 670G Hybrid Closed Loop for 7-13 Year Olds new now next Read more FDA Approves Medtronic MiniMed 670G Hybrid Closed Loop for 7-13 Year Olds Type 1 & Type 2 FDA Approves Senseonics’ Eversense 90-Day Implantable CGM, On-Body Transmitter, and Smartphone Apps new now next Read more FDA Approves Senseonics’ Eversense 90-Day Implantable CGM, On-Body Transmitter, and Smartphone Apps Type 1 & Type 2 ADA Day 4 Highlights – Updates on New Diabetes Therapies conference pearls Read more ADA Day 4 Highlights – Updates on New Diabetes Therapies Pages« first ‹ previous 1 2 3 4 5 6 7 8 9 next › last »
Type 1 & Type 2 One Drop Blood Glucose Meter Now Sends Data Directly to Apple Watch new now next Read more One Drop Blood Glucose Meter Now Sends Data Directly to Apple Watch
Type 1 & Type 2 Xeris Submits Glucagon Rescue Pen to FDA: A Dramatically Easier and Faster Treatment for Severe Hypoglycemia new now next Read more Xeris Submits Glucagon Rescue Pen to FDA: A Dramatically Easier and Faster Treatment for Severe Hypoglycemia
Type 1 & Type 2 Top 10 New Product Highlights in the AADE 2018 Exhibit Hall conference pearls Read more Top 10 New Product Highlights in the AADE 2018 Exhibit Hall
Type 1 & Type 2 Lilly Works to Get Nasal Glucagon Approved in US, Europe: A Dramatically More Convenient Treatment for Severe Hypoglycemia new now next Read more Lilly Works to Get Nasal Glucagon Approved in US, Europe: A Dramatically More Convenient Treatment for Severe Hypoglycemia
Type 1 & Type 2 Experts Focus on Drug Safety, Continuous Glucose Monitoring, and Access at 2018 ADA Forum quotable quotes Read more Experts Focus on Drug Safety, Continuous Glucose Monitoring, and Access at 2018 ADA Forum
Type 1 & Type 2 Companion Medical InPen Cleared for Use on Android & In Europe new now next Read more Companion Medical InPen Cleared for Use on Android & In Europe
Type 1 Tandem’s Hybrid Closed Loop Pivotal Study: Control-IQ and Dexcom G6 trial watch Read more Tandem’s Hybrid Closed Loop Pivotal Study: Control-IQ and Dexcom G6
Type 1 FDA Approves Medtronic MiniMed 670G Hybrid Closed Loop for 7-13 Year Olds new now next Read more FDA Approves Medtronic MiniMed 670G Hybrid Closed Loop for 7-13 Year Olds
Type 1 & Type 2 FDA Approves Senseonics’ Eversense 90-Day Implantable CGM, On-Body Transmitter, and Smartphone Apps new now next Read more FDA Approves Senseonics’ Eversense 90-Day Implantable CGM, On-Body Transmitter, and Smartphone Apps
Type 1 & Type 2 ADA Day 4 Highlights – Updates on New Diabetes Therapies conference pearls Read more ADA Day 4 Highlights – Updates on New Diabetes Therapies